Athena Capital Advisors »

Vascular Biogenics shares owned by Athena Capital Advisors

Quarter-by-quarter ownership of Vascular Biogenics shares owned by Athena Capital Advisors from 13F filings

Historical chart of Athena Capital Advisors investment in Vascular Biogenics

Tip: Access up to 7 years of quarterly data

All positions including Vascular Biogenics held by Athena Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vascular Biogenics by Athena Capital Advisors

Quarter filed Position value Share count Share price at filing
2020-06-30 $128k 100k 1.28
2020-03-31 $135k 100k 1.35
2019-09-30 $47k 35k 1.34
2019-06-30 $46k 35k 1.31
2019-03-31 $25k 11k 2.26
2018-03-31 $25k 11k 2.26
2017-12-31 $78k 11k 7.06
2017-09-30 $67k 11k 6.06
2017-03-31 $61k 11k 5.52
2016-12-31 $54k 11k 4.89
2016-06-30 $51k 11k 4.62
2016-03-31 $38k 11k 3.44
2015-12-31 $58k 11k 5.25
2015-09-30 $83k 11k 7.51
2015-06-30 $68k 11k 6.15

More positions owned by Athena Capital Advisors

Thermo Fisher Scientific (TMO)
SPDR S&P 500 ETF Trust Tr Unit (SPY)
iShares Gold Trust Ishares
Nordson Corporation (NDSN)
Apple (AAPL)
iShares Russell 3000 ETF Russell 3000 Etf (IWV)
Alphabet Inc., Class C Shares Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Progressive Corporation (PGR)
Alphabet Inc., Class A Shares Cap Stk Cl A (GOOGL)
Solaredge Technologies (SEDG)
Johnson & Johnson (JNJ)
Eaton Corp SHS (ETN)
Vanguard FTSE Developed Markets ETF Ftse Dev Mkt Etf (VEA)
Home Depot (HD)

View all positions for Athena Capital Advisors